XERS News and Press, Xeris Pharmaceuticals Inc. From 02/20/20

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that, in connection with its previously announced underwritten public ...

Viveve Medical (NASDAQ: VIVE ) +35% . More news on: Viveve Medical, Inc., Quad/Graphics, Inc., Myomo, Inc., Stocks on the move, Read more ...

Zosano Pharma (NASDAQ: ZSAN )  -47%  after pricing stock offering. More news on: Zosano Pharma Corporation, PolarityTE, Inc., PDS Biotechnology Corporation, Stocks on the move, , Read more ...

Xeris Pharmaceuticals (NASDAQ: XERS ) has priced a 9M-share public offering at $4.15 each. More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Gainers : Rexahn Pharmaceuticals (NASDAQ: REXN )  +85% . More news on: Rexahn Pharmaceuticals, Inc., Sprint Corporation, Genprex, Inc., Stocks on the move, , Read more ...

CHICAGO, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that it has commenced an ...

Xeris Pharmaceuticals (NASDAQ: XERS) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “We are including IQVIA scripts for Gvoke and glucagon below for the week ended 1/31/2020. Please note that these numbers were affected by ...

Cellect Biotechnology (NASDAQ: APOP ) +141%  on new patents . More news on: Cellect Biotechnology Ltd., Apellis Pharmaceuticals, Inc., Advaxis, Inc., Stocks on the move, Read more ...

Gainers: XERS   +21.1% . OTCQB:KNWN   +11.6% . MCHP   +4.5% . CEI   +4.1% . ACOR   +3.7% . More news on: Xeris Pharmaceuticals, Inc., Know Labs, Inc., Microchip Technology Incorporated, Stocks on the move, , News on ETFs Read more ...

Thinly traded micro cap Xeris Pharmaceuticals (NASDAQ: XERS ) is up  19%  after hours in response to positive results from the in-clinic portion of a Phase 2 clinical trial evaluating ready-to-use (RTU) glucagon for the prevention of hypoglycemia (low blood sugar) in adults wit...